|
Program Description
This webinar will provide an in-depth discussion of the sources of risk to consider in the cost of capital and forecasting in healthcare valuations. An industry risk overview will provide a chance to assess the relevant issues of healthcare reform in order to build an understanding of company-specific issues. Issues related to developing a discount rate will cover the assessment and derivation of costs of equity and debt and the weighted average cost of capital. This webinar will also discuss the corresponding risk quantified in cash flow projections. Specific practice examples that will be used in this session include internal medicine, cardiology, and dermatology.
Learning Objectives
After completing this webinar, attendees will be able to:
- Identify and assess the risks of current reform trends
- Recognize and specify the nature of current reimbursement trends and payor relationships and their impact on healthcare entities
- Specify how risk is quantified in the discount rate and cash flow projections
- Calculate an appropriate cost of capital for a subject entity
Who Should Attend
CPAs and practitioners
Presenter(s)
Mark O. Dietrich, CPA, ABV
Mr. Mark O. Dietrich is editor and contributing author to the American Health Lawyers' Association/Business Valuation Resources Guide to Healthcare Valuation, 3rd Edition, and the Guide to Healthcare Industry Compensation and Valuation. He is principal author of Business Valuation Resources’ Guide to Physician Practice Valuation, 2nd Edition, and co-author with Gregory Anderson, CPA/ABV of The Financial Professional's Guide to Healthcare Reform.
Mr. Dietrich is also co-author of PPC's Guide to Healthcare Consulting as well as dozens of articles on valuation, taxation, and the healthcare regulatory environment. Mr. Dietrich's career experience includes serving as partner-in-charge of the annual audit of an 80-physician, tax-exempt faculty group practice and the negotiation of Medicare Advantage contracts. He has completed more than 350 valuation engagements in the healthcare industry and has served as an expert witness in regulatory matters. Mr. Dietrich is a regular speaker at national and international conferences on healthcare reform, valuation, and other topics. He has presented at NACVA and ASA conferences as well as webinars related to valuation.
Laura Pfeiffenberger, MBA, MSA
Ms. Laura Pfeiffenberger is a director in the business valuation and litigation support group at Meyers, Harrison & Pia, LLC. Ms. Pfeiffenberger has significant experience in matters involving economic damages, including the determination of damages related to contracts, torts, infringement of intellectual property, personal injury/wrongful termination, post-acquisition disputes, and shareholder disputes. As one of the firm’s healthcare valuation practice leaders, Ms. Pfeiffenberger's industry focus on healthcare services provides clients valuation, transaction, and business arrangement guidance in the complex world of today’s post-reform marketplace.
In addition to contributing to multiple publications, Ms. Pfeiffenberger has spoken at the AICPA Forensic & Valuation Services Conference and the NACVA/CTI Matrimonial Litigation Support Workshops. She has also presented for Business Valuation Resources’ 2012 webinar symposium on economic damages.
CPE Credit |
Mark O. Dietrich, CPA, ABV
Laura Pfeiffenberger, MBA, MSA
|
